SenesTech Signs Expanded Distribution Agreement for Evolve™ Soft Bait Sales into the United Arab Emirates (UAE)

News provided by

Jan 02, 2024, 09:00 ET

UAE Expansion Continues Regional Strategy working with Pesterminators

PHOENIX, Jan. 2, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces the expansion of its distribution agreement with Pesterminators Pvt Ltd to include the deployment of Evolve^TM. This expansion also extends the territory into the United Arab Emirates (UAE) market through the Pesterminators subsidiary, TCS Global for General Trading LLC in UAE.

"This expansion is part of our regional strategy as we collaborate with Pesterminators and follows the successful deployment of our ContraPest products into the Maldives. This expanded distribution agreement incorporates their initial stocking order for Evolve as well as an expanded territory that now includes the UAE," said Joel Fruendt, SenesTech's president and CEO.

"The UAE has implemented strict measures in recent years to control and prevent the use of harmful chemicals. Health officials in Dubai have issued warnings about hiring illegal companies, with municipal regulations prohibiting the importing, handling, and trading of pesticides without permission, and limiting the use of poisons in sensitive areas. Pesterminators is committed to introducing sustainable solutions for the pest management segment and holds a solid position in the UAE. Evolve aligns well into our pest control practice and meets regulatory requirements in the region," said Mr. Sathes Ramachandran, CEO of Pesterminators Pvt Ltd and TCS Global, UAE.

"Further regional expansion is expected as we proceed systematically with Pesterminators," concluded Mr. Fruendt.

About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations through fertility control. We are experts in fertility control to manage animal pest populations. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

For more information visit https://senestech.com/ and https://contrapeststore.com.

Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that Pesterminators is an excellent partner for us; and our belief that we will be able to expand our work with Pesterminators in the UAE and the South Asian region. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the impacts and implications of the COVID-19 pandemic, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:
Investors:
Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, [email protected]

Company:
Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143 x825

SOURCE SenesTech, Inc.